http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6300367-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93bb978c9fe97c06684421435a0f7559 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
| filingDate | 1999-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2001-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab3bb5f5f30ed72d8e118cecf884282c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37ca9ca45a5158c1528fca294dae6069 |
| publicationDate | 2001-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6300367-B1 |
| titleOfInvention | Composition for and method of preventing or treating breast cancer |
| abstract | The present invention is a composition for preventing, minimizing, or reversing the development or growth of breast cancer. The composition contains a combination of a selective estrogen receptor modulator selected from at least one of raloxifene, droloxifene, toremifene, 4′-iodotamoxifen, and idoxifene and at least one isoflavone selected from genistein, daidzein, biochanin A, formononetin, and their respective naturally occurring glucosides and glucoside conjugates. The present invention also provides a method of preventing, minimizng, or reversing the development or growth of breast cancer in which a selective estrogen receptor modulator selected from at least one of raloxifene, droloxifene, toremifene, 4′-iodotamoxifen, and idoxifene is co-administered with at least one isoflavone selected from genistein, daidzein, biochanin A, formononetin, and their naturally occuring glucosides and glucoside conjugates to a woman having or predisposed to having breast cancer. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013134311-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8377484-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009176871-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005002900-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009054517-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006093667-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005079156-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7176221-B2 |
| priorityDate | 1999-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 432.